DD262530A5 - Verfahren zur herstellung einer pharmazeutischen waessrigen gelzubereitung - Google Patents
Verfahren zur herstellung einer pharmazeutischen waessrigen gelzubereitung Download PDFInfo
- Publication number
- DD262530A5 DD262530A5 DD87302067A DD30206787A DD262530A5 DD 262530 A5 DD262530 A5 DD 262530A5 DD 87302067 A DD87302067 A DD 87302067A DD 30206787 A DD30206787 A DD 30206787A DD 262530 A5 DD262530 A5 DD 262530A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- pharmaceutical
- gel preparation
- preparation
- gel
- waferen
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title description 2
- 229920013820 alkyl cellulose Polymers 0.000 claims abstract description 6
- 230000000699 topical effect Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 4
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 4
- 239000008186 active pharmaceutical agent Substances 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 8
- 239000000600 sorbitol Substances 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- -1 alkyl radicals Chemical class 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000000622 irritating effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940042129 topical gel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Jellies, Jams, And Syrups (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863614095 DE3614095A1 (de) | 1986-04-25 | 1986-04-25 | Oxyalkylcellulose enthaltende gelzubereitung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD262530A5 true DD262530A5 (de) | 1988-11-30 |
Family
ID=6299560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD87302067A DD262530A5 (de) | 1986-04-25 | 1987-04-23 | Verfahren zur herstellung einer pharmazeutischen waessrigen gelzubereitung |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0247362A3 (da) |
| JP (1) | JPS62254763A (da) |
| CN (1) | CN87103139A (da) |
| AU (1) | AU7196487A (da) |
| DD (1) | DD262530A5 (da) |
| DE (1) | DE3614095A1 (da) |
| DK (1) | DK209087A (da) |
| FI (1) | FI871811L (da) |
| HU (1) | HUT43783A (da) |
| IL (1) | IL82325A0 (da) |
| NO (1) | NO871720L (da) |
| PT (1) | PT84738B (da) |
| YU (1) | YU75187A (da) |
| ZA (1) | ZA872934B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658592A (en) * | 1994-05-13 | 1997-08-19 | Kuraray Co., Ltd. | Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane |
| WO2014172040A1 (en) * | 2013-03-15 | 2014-10-23 | Synedgen Inc. | Compositions and methods of use for wound healing |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE943793C (de) * | 1955-03-16 | 1956-06-01 | Kade Pharmazeutische Fabrik Dr | Verfahren zur Herstellung eines Mittels zur Behandlung von Brandwunden |
| AU7776275A (en) * | 1974-04-11 | 1976-08-05 | Warner Lambert Co | Production of base for topical steroids |
| US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
| JPS59501159A (ja) * | 1982-06-24 | 1984-07-05 | スミス、ロバ−ト・アラン | 薬用ゲル組成物 |
| DE3243546A1 (de) * | 1982-11-25 | 1984-05-30 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle |
| DE3435113A1 (de) * | 1984-05-07 | 1986-04-03 | Gödecke AG, 7800 Freiburg | Pharmazeutische topische zubereitungen zur foerderung der wundgranulation und epithelisation |
| BE902226R (fr) * | 1985-04-18 | 1985-08-16 | Kowa Co | Onguent gelifie analgesique et anti-inflammatoire. |
-
1986
- 1986-04-25 DE DE19863614095 patent/DE3614095A1/de not_active Withdrawn
-
1987
- 1987-04-22 PT PT84738A patent/PT84738B/pt unknown
- 1987-04-22 JP JP62097656A patent/JPS62254763A/ja active Pending
- 1987-04-23 DD DD87302067A patent/DD262530A5/de unknown
- 1987-04-24 DK DK209087A patent/DK209087A/da not_active Application Discontinuation
- 1987-04-24 FI FI871811A patent/FI871811L/fi not_active Application Discontinuation
- 1987-04-24 EP EP87105999A patent/EP0247362A3/de not_active Withdrawn
- 1987-04-24 ZA ZA872934A patent/ZA872934B/xx unknown
- 1987-04-24 IL IL82325A patent/IL82325A0/xx unknown
- 1987-04-24 YU YU00751/87A patent/YU75187A/xx unknown
- 1987-04-24 HU HU871804A patent/HUT43783A/hu unknown
- 1987-04-24 AU AU71964/87A patent/AU7196487A/en not_active Abandoned
- 1987-04-24 NO NO871720A patent/NO871720L/no unknown
- 1987-04-25 CN CN198787103139A patent/CN87103139A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI871811A7 (fi) | 1987-10-26 |
| PT84738A (en) | 1987-05-01 |
| PT84738B (en) | 1989-06-08 |
| EP0247362A3 (de) | 1988-10-26 |
| AU7196487A (en) | 1987-10-29 |
| ZA872934B (en) | 1987-10-19 |
| NO871720L (no) | 1987-10-26 |
| JPS62254763A (ja) | 1987-11-06 |
| IL82325A0 (en) | 1987-10-30 |
| YU75187A (en) | 1988-12-31 |
| NO871720D0 (no) | 1987-04-24 |
| DK209087A (da) | 1987-10-26 |
| FI871811L (fi) | 1987-10-26 |
| CN87103139A (zh) | 1987-11-18 |
| EP0247362A2 (de) | 1987-12-02 |
| DK209087D0 (da) | 1987-04-24 |
| DE3614095A1 (de) | 1987-10-29 |
| FI871811A0 (fi) | 1987-04-24 |
| HUT43783A (en) | 1987-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69527765T2 (de) | Verwendung von Hyaluronsäure oder sein Salz zur Behandlung von Hauterkrankungen | |
| DE3872521T3 (de) | Steroide enthaltende flüssigkeit. | |
| DE60032543T2 (de) | Topisch verabreichbare Zinkzusammensetzungen | |
| DE3687458T2 (de) | Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln | |
| DE69736998T2 (de) | Nitroimidazol enthaltende gelzusammensetzung | |
| DE2207294C2 (de) | Topische Salbengrundlage | |
| DE2947742C2 (de) | Arzneimittel, enthaltend β-Cyclodextrin | |
| DE10361022A1 (de) | Topische Zubereitungen enthaltend Dimethylsulfoxid und Dexpanthenol | |
| DD298352A5 (de) | Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung | |
| DD284602A5 (de) | Verfahren zur herstellung von pharmazeutischen zubereitungsformen | |
| DE60020768T2 (de) | Heparin und Diclofenac enthaltendes topisches Pflaster | |
| DE69117800T2 (de) | Xylobiose enthaltende Zusammensetzung | |
| EP1909858B1 (de) | Hydrogel | |
| DE69019151T2 (de) | Salbe enthaltend Deprodone proprionate. | |
| DE2601489A1 (de) | Tretinoin enthaltende gelpraeparate | |
| WO1989006962A1 (fr) | Agent contenant de la sulfadiazine d'argent pour traitement topique externe | |
| DE60011686T2 (de) | Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis | |
| WO2009024275A1 (de) | Wasser- und wirkstoffhaltiges gel | |
| DE2316597C3 (de) | Zur topischen Applikation auf menschliches oder tierisches Gewebe geeignete wirkstoffhalfige Zubereitung | |
| DE2202964A1 (de) | Stabile,milde,nichttoxische,kampferhaltige Zubereitungen fuer die oertliche Behandlung mit entzuendungshemmender,antipruretischer und antibakterieller Wirkung | |
| DE2515594C3 (de) | Verfahren zur Herstellung eines stabilen, topisch aktiven Geles | |
| DE2522178A1 (de) | Granulate und pulver zur herstellung von salben | |
| EP0450123B1 (de) | Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung | |
| DE69402259T2 (de) | Zusammensetzungen enthaltend 8-Hydroxychinolin zur Behandlung hyperproliferativer Hautkrankheiten | |
| DD262530A5 (de) | Verfahren zur herstellung einer pharmazeutischen waessrigen gelzubereitung |